期刊档案
CANCER BIOLOGY & THERAPY
— · ISSN 1538-4047 · 医学-肿瘤学
数据可追溯 · letpub-v6 · 更新于 2026-08-26期刊简介
研究范围与定位
Cancer, the second leading cause of death, is a heterogenous group of over 100 diseases. Cancer is characterized by disordered and deregulated cellular and stromal proliferation accompanied by reduced cell death with the ability to survive under stresses of nutrient and growth factor deprivation, hypoxia, and loss of cell-to-cell contacts. At the molecular level, cancer is a genetic disease that develops due to the accumulation of mutations over time in somatic cells. The phenotype includes genomic instability and chromosomal aneuploidy that allows for acceleration of genetic change. Malignant transformation and tumor progression of any cell requires immortalization, loss of checkpoint control, deregulation of growth, and survival. A tremendous amount has been learned about the numerous cellular and molecular genetic changes and the host-tumor interactions that accompany tumor development and progression. It is the goal of the field of Molecular Oncology to use this knowledge to understand cancer pathogenesis and drug action, as well as to develop more effective diagnostic and therapeutic strategies for cancer. This includes preventative strategies as well as approaches to treat metastases. With the availability of the human genome sequence and genomic and proteomic approaches, a wealth of tools and resources are generating even more information. The challenge will be to make biological sense out of the information, to develop appropriate models and hypotheses and to translate information for the clinicians and the benefit of their patients. Cancer Biology & Therapy aims to publish original research on the molecular basis of cancer, including articles with translational relevance to diagnosis or therapy. We will include timely reviews covering the broad scope of the journal. The journal will also publish op-ed pieces and meeting reports of interest. The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats. The journal and the outstanding Editorial Board will strive to maintain the highest standards for excellence in all activities to generate a valuable resource.
结构化分区
学科分区明细
不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值。
《新锐期刊分区表》( 2026年3月发布)
2026-03 · 2 个学科记录
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 2区 |
| 小类 | 肿瘤学ONCOLOGY | 3区 |
期刊分区表( 2025年3月升级版)
2025-03 · 2 个学科记录
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 2区 |
| 小类 | 肿瘤学ONCOLOGY | 3区 |
期刊分区表( 2023年12月旧的升级版)
2023-12 · 2 个学科记录
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4区 |
| 小类 | 肿瘤学ONCOLOGY | 4区 |
期刊档案
出版与身份
- 期刊ISSN
- 1538-4047
- E-ISSN
- 1555-8576
- 是否OA开放访问
- NoLetPub与Taylor & Francis签署APC支持服务战略合作协议,选择APC支持服务可享受:多样化支付选项,国税发票,加速发表,京东购物卡福利。了解详情>>>
- 通讯方式
- LANDES BIOSCIENCE, 1002 WEST AVENUE, 2ND FLOOR, AUSTIN, USA, TX, 78701
- 出版商
- Landes Bioscience
- 出版国家或地区
- UNITED STATES
- 出版语言
- English
- 出版周期
- Monthly
- 出版年份
- 2002
期刊档案
研究范围
- 期刊简介
- Cancer, the second leading cause of death, is a heterogenous group of over 100 diseases. Cancer is characterized by disordered and deregulated cellular and stromal proliferation accompanied by reduced cell death with the ability to survive under stresses of nutrient and growth factor deprivation, hypoxia, and loss of cell-to-cell contacts. At the molecular level, cancer is a genetic disease that develops due to the accumulation of mutations over time in somatic cells. The phenotype includes genomic instability and chromosomal aneuploidy that allows for acceleration of genetic change. Malignant transformation and tumor progression of any cell requires immortalization, loss of checkpoint control, deregulation of growth, and survival. A tremendous amount has been learned about the numerous cellular and molecular genetic changes and the host-tumor interactions that accompany tumor development and progression. It is the goal of the field of Molecular Oncology to use this knowledge to understand cancer pathogenesis and drug action, as well as to develop more effective diagnostic and therapeutic strategies for cancer. This includes preventative strategies as well as approaches to treat metastases. With the availability of the human genome sequence and genomic and proteomic approaches, a wealth of tools and resources are generating even more information. The challenge will be to make biological sense out of the information, to develop appropriate models and hypotheses and to translate information for the clinicians and the benefit of their patients. Cancer Biology & Therapy aims to publish original research on the molecular basis of cancer, including articles with translational relevance to diagnosis or therapy. We will include timely reviews covering the broad scope of the journal. The journal will also publish op-ed pieces and meeting reports of interest. The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats. The journal and the outstanding Editorial Board will strive to maintain the highest standards for excellence in all activities to generate a valuable resource.
- 涉及的研究方向
- 医学-肿瘤学
期刊档案
指标与活跃度
- 2025-2026最新IF(数据来源于网友提供)
- 注册或登录后,查看IF
- 实时影响因子
- 截止2026年5月06日:5.7
- 2025-2026自引率
- 0.0%点击查看自引率趋势图
- 五年IF(数据来源于网友提供)
- 4.504数据由网友[小小笛子]收集提供
- h-index
- 101
- CiteScore ( 2026年6月最新版)
- CiteScoreSJRSNIPCiteScore排名8.401.4070.987学科分区排名百分位大类:Medicine小类:OncologyQ172 / 428 83% 大类:Medicine小类:PharmacologyQ156 / 328 83% 大类:Medicine小类:Cancer ResearchQ261 / 233 74% 大类:Medicine小类:Molecular MedicineQ248 / 179 73%
- 年文章数
- 81点击查看年文章数趋势图
- Gold OA文章占比
- 100.00%
- 研究类文章占比:文章 ÷(文章 + 综述)
- 82.72%
期刊档案
分区、收录与风险
- WOS期刊JCR分区 ( 2025-2026年最新版)
- 注册或登录后,查看WOS分区等级
- 期刊分区表预警名单
- 2026年03月发布的新锐学术版:不在预警名单中2025年03月发布的2025版:不在预警名单中2024年02月发布的2024版:不在预警名单中2023年01月发布的2023版:不在预警名单中2021年12月发布的2021版:不在预警名单中2020年12月发布的2020版:不在预警名单中
- SCI期刊收录coverage
- Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)Scopus (CiteScore)Directory of Open Access Journals (DOAJ)
- PubMed Central (PMC)链接
- 访问官方页面 ↗
期刊档案
投稿与评审
来源与统计口径
来源:LetPub 原始详情页 ↗。投稿经验仅展示聚合统计,不公开第三方正文或用户标识。当前聚合样本:暂无。